Renal COX-2, Cytokines and 20-HETE: Tubular and Vascular Mechanisms

E-ISSN： 1873-4286|10|6|613-626

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.6, 2004-02, pp. : 613-626

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COX-2 selective inhibitors: analysis of the renal effects

By Perazella Mark A

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 53-64

Informa Healthcare

Access to resources Recommend Favorite

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

By de Gaetano G. Donati M.B. Cerletti C.

Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. : 245-252

Elsevier

Access to resources Recommend Favorite

Potential Mechanisms of COX-2 Selective Inhibitors Affecting Cardiovascular Risk

By Smith Howard S.

Journal of Cancer Pain & Symptom Palliation, Vol. 2, Iss. 3, 2008-01 ,pp. : 5-18

Haworth Press

Access to resources Recommend Favorite

Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-01 ,pp. : 505-516

Bentham Science Publishers

Access to resources Recommend Favorite

Hydroxytyrosol inhibits pro-inflammatory cytokines, iNOS, and COX-2 expression in human monocytic cells

By Zhang Xiaomei

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 379, Iss. 6, 2009-06 ,pp. : 581-586

Springer Publishing Company

Access to resources Recommend Favorite